These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 4002242)

  • 1. Configuration of necine pyrroles--toxic metabolites of pyrrolizidine alkaloids.
    Kedzierski B; Buhler DR
    Toxicol Lett; 1985 May; 25(2):115-9. PubMed ID: 4002242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation of DHP-derived DNA adducts from metabolic activation of the prototype heliotridine-type pyrrolizidine alkaloid, heliotrine.
    Xia Q; Yan J; Chou MW; Fu PP
    Toxicol Lett; 2008 May; 178(2):77-82. PubMed ID: 18395999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 9-Glutathionyl-6,7-dihydro-1-hydroxymethyl-5H-pyrrolizine Is the Major Pyrrolic Glutathione Conjugate of Retronecine-Type Pyrrolizidine Alkaloids in Liver Microsomes and in Rats.
    Chen M; Li L; Zhong D; Shen S; Zheng J; Chen X
    Chem Res Toxicol; 2016 Feb; 29(2):180-9. PubMed ID: 26761523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human liver microsomal reduction of pyrrolizidine alkaloid N-oxides to form the corresponding carcinogenic parent alkaloid.
    Wang YP; Yan J; Fu PP; Chou MW
    Toxicol Lett; 2005 Mar; 155(3):411-20. PubMed ID: 15649625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microsomal metabolism of pyrrolizidine alkaloids from Senecio jacobaea. Isolation and quantification of 6,7-dihydro-7-hydroxy-1-hydroxymethyl-5H-pyrrolizine and N-oxides by high performance liquid chromatography.
    Ramsdell HS; Kedzierski B; Buhler DR
    Drug Metab Dispos; 1987; 15(1):32-6. PubMed ID: 2881756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of structural features to pyrrolic metabolites in livers of rats given pyrrolizidine alkaloids and derivatives.
    Mattocks AR
    Chem Biol Interact; 1981 Jun; 35(3):301-10. PubMed ID: 7226276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microsomal formation of a pyrrolic alcohol glutathione conjugate of the pyrrolizidine alkaloid senecionine.
    Reed RL; Miranda CL; Kedzierski B; Henderson MC; Buhler DR
    Xenobiotica; 1992 Nov; 22(11):1321-7. PubMed ID: 1492424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic activation of retronecine and retronecine N-oxide - formation of DHP-derived DNA adducts.
    Yan J; Xia Q; Chou MW; Fu PP
    Toxicol Ind Health; 2008 Apr; 24(3):181-8. PubMed ID: 18842697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyrrolic and N-oxide metabolites formed from pyrrolizidine alkaloids by hepatic microsomes in vitro: relevance to in vivo hepatotoxicity.
    Mattocks AR; Bird I
    Chem Biol Interact; 1983 Feb; 43(2):209-22. PubMed ID: 6825198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Method for determination of pyrrolizidine alkaloids and their metabolites by high-performance liquid chromatography.
    Kedzierski B; Buhler DR
    Anal Biochem; 1986 Jan; 152(1):59-65. PubMed ID: 3954045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The formation of 6,7-dihydro-7-hydroxy-1-hydroxy-methyl-5H-pyrrolizine, a metabolite of pyrrolizidine alkaloids.
    Kedzierski B; Buhler DR
    Chem Biol Interact; 1986 Feb; 57(2):217-22. PubMed ID: 3955792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic activation of pyrrolizidine alkaloids by human, rat and avocado microsomes.
    Couet CE; Hopley J; Hanley AB
    Toxicon; 1996 Sep; 34(9):1058-61. PubMed ID: 8896199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two dihydropyrrolizine alkaloid metabolites isolated from mouse hepatic microsomes in vitro.
    Segall HJ; Dallas JL; Haddon WF
    Drug Metab Dispos; 1984; 12(1):68-71. PubMed ID: 6141915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of [14C]monocrotaline by isolated perfused rat liver.
    Lamé MW; Jones AD; Morin D; Segall HJ
    Drug Metab Dispos; 1991; 19(2):516-24. PubMed ID: 1676664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro biotransformation of pyrrolizidine alkaloids in different species: part II-identification and quantitative assessment of the metabolite profile of six structurally different pyrrolizidine alkaloids.
    Geburek I; Schrenk D; These A
    Arch Toxicol; 2020 Nov; 94(11):3759-3774. PubMed ID: 32880719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microsomal formation of a pyrrolic alcohol glutathione conjugate of clivorine. Firm evidence for the formation of a pyrrolic metabolite of an otonecine-type pyrrolizidine alkaloid.
    Lin G; Cui YY; Hawes EM
    Drug Metab Dispos; 1998 Feb; 26(2):181-4. PubMed ID: 9456306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species differences in the hepatic microsomal metabolism of the pyrrolizidine alkaloid senecionine.
    Winter CK; Segall HJ; Jones AD
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1988; 90(2):429-33. PubMed ID: 2903002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The comparative metabolism of the four pyrrolizidine alkaloids, seneciphylline, retrorsine, monocrotaline, and trichodesmine in the isolated, perfused rat liver.
    Yan CC; Cooper RA; Huxtable RJ
    Toxicol Appl Pharmacol; 1995 Aug; 133(2):277-84. PubMed ID: 7645024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic activation of pyrrolizidine alkaloids: insights into the structural and enzymatic basis.
    Ruan J; Yang M; Fu P; Ye Y; Lin G
    Chem Res Toxicol; 2014 Jun; 27(6):1030-9. PubMed ID: 24836403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic activation of the tumorigenic pyrrolizidine alkaloid, retrorsine, leading to DNA adduct formation in vivo.
    Wang YP; Fu PP; Chou MW
    Int J Environ Res Public Health; 2005 Apr; 2(1):74-9. PubMed ID: 16705803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.